Context Invited update on the management of systemic autoimmune Graves disease (GD)
and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original …

Graves orbitopathy, also known as thyroid eye disease or thyroid-associated orbitopathy, is
visually disabling, cosmetically disfiguring and has a substantial negative impact on a …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies.
Appropriate treatment requires an accurate diagnosis and is influenced by coexisting …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though
severe forms are rare. Management of GO is often suboptimal, largely because available …

Objective To demonstrate the efficacy of the anti-interleukin-6 receptor monoclonal antibody
tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy …

Hyperthyroidism caused by Graves' disease (GD) is a relatively rare disease in children.
Treatment options are the same as in adults-anti-thyroid drugs (ATD), radio-active iodine …

Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies.
Appropriate treatment requires an accurate diagnosis and is influenced by coexisting …

Graves’ Disease | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Background: Preliminary studies have shown that rituximab (RTX) is effective in the
treatment of active Graves' orbitopathy (GO). Methods: We conducted a double-blind …